Novartis challenges Pfizer with strong breast cancer drug data

 

An experimental Novartis pill given with an older drug kept advanced breast cancer in check far longer than standard treatment alone, putting it on track to challenge Pfizer’s blockbuster Ibrance, data showed on Saturday.

Patients taking ribociclib with letrozole were 44 percent less likely to see their disease progress or to die, a keenly awaited clinical trial found.

Leave a Reply

Your email address will not be published.

x

Check Also

امیتابھ کی فلم سیٹ پر کھلونا بائیک چلانے کی تصاویر وائرل

امیتابھ کی فلم سیٹ پر کھلونا بائیک چلانے کی تصاویر وائرل

بالی ووڈ کے شہنشاہ امیتابھ بچن نے سیٹ پر کچھ تفریحی لمحات کی ایک جھلک ...

%d bloggers like this: